Education
About Us
Working with TipRanks
Follow Us
Doximity (DOCS)
NYSE:DOCS
DOCS Stock Chart & Stats
$63.99
-$0.33(-0.59%)
At close: 4:00 PM EST
$63.99
-$0.33(-0.59%)
Day’s Range― - ―
52-Week Range$41.82 - $85.21
Previous CloseN/A
Volume296.07K
Average Volume (3M)1.30M
Market Cap
$12.33B
Enterprise Value$11.51B
Total Cash (Recent Filing)$840.97M
Total Debt (Recent Filing)$11.84M
Price to Earnings (P/E)56.5
Beta1.33
Next Earnings
Nov 06, 2025EPS Estimate
0.38Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding136,400,250
10 Day Avg. Volume1,184,637
30 Day Avg. Volume1,303,851
Financial Highlights & Ratios
PEG Ratio0.92
Price to Book (P/B)10.01
Price to Sales (P/S)19.01
P/FCF Ratio40.65
Enterprise Value/Market Cap0.93
Enterprise Value/Revenue19.52
Enterprise Value/Gross Profit21.65
Enterprise Value/Ebitda44.42
Forecast
1Y Price Target
$71.38Price Target Upside11.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering17
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Financial PerformanceDoximity boasts strong financial metrics, including a 118% Net Revenue Retention (NRR), and impressive adjusted EBITDA margin and free cash flow generation.
Platform EngagementDoximityGPT is beginning to drive higher engagement on the platform, a key development to watch regarding monetization into 2026.
Revenue GrowthDoximity's revenue growth is anticipated to accelerate significantly as pharmaceutical manufacturers shift their advertising spend to the HCP channel.
Bears Say
Competitive PressureOpenEvidence's rapid HCP engagement growth may lead to a recalibration of biopharma ad budgets, potentially pressuring Doximity's growth trajectory.
Growth VisibilityDOCS growth visibility is limited by uncertain pharma digital advertising trends.
Valuation ConcernsThe current DOCS valuation premium is considered excessive, warranting a relative UW rating within the broader Vertical SaaS universe.
Doximity News
DOCS FAQ
What was Doximity’s price range in the past 12 months?
Doximity lowest stock price was $41.82 and its highest was $85.21 in the past 12 months.
What is Doximity’s market cap?
Doximity’s market cap is $12.33B.
When is Doximity’s upcoming earnings report date?
Doximity’s upcoming earnings report date is Nov 06, 2025 which is today.
How were Doximity’s earnings last quarter?
Currently, no data Available
Is Doximity overvalued?
According to Wall Street analysts Doximity’s price is currently Undervalued.
Does Doximity pay dividends?
Doximity does not currently pay dividends.
What is Doximity’s EPS estimate?
Doximity’s EPS estimate is 0.38.
How many shares outstanding does Doximity have?
Doximity has 136,400,250 shares outstanding.
What happened to Doximity’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Doximity?
Currently, no hedge funds are holding shares in DOCS
Doximity Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$71.38 (11.55% Upside)
$71.38 (11.55% Upside)
Blogger Sentiment
Bullish
DOCS Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 148.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.6%
Last 30 Days ▼ 3.6%
Last 30 Days ▼ 3.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
57.38%
12-Months-Change
Fundamentals
Return on Equity
24.25%
Trailing 12-Months
Asset Growth
12.20%
Trailing 12-Months
Company Description
Doximity
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
DOCS Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a largely positive outlook with strong financial performance, significant user growth, and successful product launches. However, there are concerns regarding policy uncertainties and the lack of immediate revenue contribution from recent acquisitions.View all DOCS earnings summariesDOCS Revenue Breakdown
93.00% Subscription
7.00% Other
DOCS Stock 12 Month Forecast
Average Price Target
$71.38
▲(11.55% Upside)
Technical Analysis
Omnicell
―
Evolent Health
―
Teladoc
―
Definitive Healthcare Corp
―
Tempus AI, Inc. Class A
―
Ownership Overview
2.42% Insiders
31.03% Mutual Funds
0.06% Other Institutional Investors
46.55% Public Companies and Individual Investors